| Utestående aktier | 7,190,876 shares |
| Insideraktier | 801 656 shares |
| Insynsägande | 11,15 % |
| Totalt antal insynspersoner | 21 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
7901 out of 11220Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Motus GI Holdings, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Abv, Llc - | 591 481 | 33 799 | |
| Ascent Biomedical Ventures II, L.P. - | 591 481 | 33 799 | |
|
Joseph Edelman
10% Owner -
|
2 660 542 | 152 031 | |
| Larry N Feinberg - | 0 | 0 | |
| David P Hochman Director - [D] | 291 669 | 16 667 | |
| Jacobs Gary E. Director - [D] | 771 289 | 44 074 | |
| Shervin J Korangy Director - [D] | 190 189 | 10 868 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Moran Timothy P. Chief Executive Officer, Director - [D] [O] | 657 701 | 37 583 | |
| Samuel R Md Nussbaum Director - [D] | 97 689 | 5 582 | |
| Sonja Nelson Director - [D] | 100 709 | 5 755 | |
|
Oracle Partners Lp
10% Owner -
|
0 | 0 | |
|
Orchestra BioMed Holdings, Inc.
10% Owner -
|
804 096 | 53 606 | |
|
Orchestra BioMed, Inc.
10% Owner -
|
4 000 000 | 228 571 | |
|
Orchestra MOTUS Co-Investment Partners, LLC
10% Owner -
|
2 189 860 | 125 135 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Orchestra Medical Ventures II GP, LLC - | 0 | 0 | |
|
Perceptive Advisors Llc
10% Owner -
|
2 660 542 | 152 031 | |
|
Perceptive Life Sciences Master Fund Ltd
10% Owner -
|
2 660 542 | 152 031 | |
| Mark Pomeranz President and COO, Director - [D] [O] | 259 857 | 14 849 | |
| Gary J Pruden Director - [D] | 263 116 | 15 035 | |
| Darren Sherman Director - [D] | 194 602 | 11 120 | |
| Andrew Lawrence Taylor Chief Financial Officer - [O] | 230 682 | 13 182 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i MOTS / Motus GI Holdings, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i MOTS / Motus GI Holdings, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-22 | 3 | Orchestra BioMed Holdings, Inc. | MOTS | Common Stock | D | 804 096 | ||||||||
| 2022-02-11 | 2022-02-10 | 4 | Nelson Sonja | MOTS | Stock Option (right to buy) | D | 0,46 | 50 000 | 50 000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 0,46 | 175 000 | 175 000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 175 000 | 657 701 | ||||||
| 2022-02-11 | 2022-02-10 | 4 | Taylor Andrew Lawrence | MOTS | Stock Option (right to buy) | D | 0,46 | 95 000 | 95 000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 95 000 | 230 682 | ||||||
| 2022-02-11 | 2022-02-10 | 4 | Pomeranz Mark | MOTS | Stock Option (right to buy) | D | 0,46 | 95 000 | 95 000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 95 000 | 259 857 | ||||||
| 2022-02-11 | 2022-02-10 | 4 | Hochman David P | MOTS | Stock Option (right to buy) | D | 0,46 | 50 000 | 50 000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Korangy Shervin J | MOTS | Stock Option (right to buy) | D | 0,46 | 50 000 | 50 000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Sherman Darren | MOTS | Stock Option (right to buy) | D | 0,46 | 50 000 | 50 000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Pruden Gary J | MOTS | Stock Option (right to buy) | D | 0,46 | 50 000 | 50 000 | |||||
| 2022-01-07 | 2022-01-05 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 90 521 | 194 602 | ||||||
| 2022-01-07 | 2022-01-05 | 4 | Nelson Sonja | MOTS | Common Stock, par value $0.0001 per share | D | 82 500 | 100 709 | ||||||
| 2022-01-07 | 2022-01-05 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 127 083 | 291 669 | ||||||
| 2022-01-07 | 2022-01-05 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 82 500 | 190 189 | ||||||
| 2022-01-07 | 2022-01-05 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 106 563 | 263 116 | ||||||
| 2021-11-22 | 2021-11-19 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 0,5106 | 2 000 | 1 | 135 682 | ||||
| 2021-11-22 | 2021-11-19 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 0,5108 | 4 000 | 2 | 164 857 | ||||
| 2021-11-22 | 2021-11-19 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 0,5214 | 10 000 | 5 | 482 701 | ||||
| 2021-06-23 | 2021-06-22 | 4 | Nelson Sonja | MOTS | Stock Option (right to buy) | D | 1,04 | 50 000 | 50 000 | |||||
| 2021-06-23 | 2021-06-22 | 4 | Nelson Sonja | MOTS | Common Stock, par value $0.0001 per share | D | 18 209 | 18 209 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 1,78 | 141 000 | 141 000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 141 000 | 472 701 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Sherman Darren | MOTS | Stock Option (right to buy) | D | 1,78 | 30 000 | 30 000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 22 191 | 104 081 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 30 000 | 81 890 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Pruden Gary J | MOTS | Stock Option (right to buy) | D | 1,78 | 30 000 | 30 000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 26 124 | 156 553 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 30 000 | 130 429 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Stock Option (right to buy) | D | 1,78 | 30 000 | 30 000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 20 225 | 97 689 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 30 000 | 77 464 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Taylor Andrew Lawrence | MOTS | Stock Option (right to buy) | D | 1,78 | 60 000 | 60 000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 60 000 | 133 682 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Korangy Shervin J | MOTS | Stock Option (right to buy) | D | 1,78 | 30 000 | 30 000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 20 225 | 107 689 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 30 000 | 87 464 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Hochman David P | MOTS | Stock Option (right to buy) | D | 1,78 | 40 000 | 40 000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 32 472 | 164 586 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 40 000 | 132 114 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Pomeranz Mark | MOTS | Stock Option (right to buy) | D | 1,78 | 65 000 | 65 000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 65 000 | 160 857 | ||||||
| 2021-02-05 | 2021-01-26 | 4 | FEINBERG LARRY N | MOTS | Common Stock | I | 1,9000 | −30 000 | −57 | 0 | ||||
| 2021-02-05 | 2021-01-26 | 4 | FEINBERG LARRY N | MOTS | Common Stock | I | 1,9034 | −29 115 | −55 | 105 885 | ||||
| 2021-01-22 | 2021-01-22 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 1,4800 | −550 000 | −814 | 2 660 542 | ||||
| 2021-01-22 | 2021-01-21 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 1,6800 | −674 352 | −1 133 | 3 210 542 | ||||
| 2021-01-22 | 2021-01-20 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 1,8000 | −325 648 | −586 | 3 884 894 | ||||
| 2021-01-14 | 2021-01-12 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 9 144 | 51 890 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 10 764 | 100 429 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 8 334 | 47 464 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 8 334 | 57 464 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 15 741 | 92 114 | ||||||
| 2020-12-18 | 2020-12-17 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 0,9700 | 3 000 | 3 | 42 746 | ||||
| 2020-12-10 | 2020-12-09 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 1,0800 | 1 000 | 1 | 95 857 | ||||
| 2020-12-10 | 2020-12-09 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 1,0800 | 1 000 | 1 | 73 682 | ||||
| 2020-12-07 | 2020-12-04 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 0,9930 | 5 000 | 5 | 76 373 | ||||
| 2020-12-07 | 2020-12-04 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 0,9644 | 10 000 | 10 | 331 701 | ||||
| 2020-11-13 | 2020-11-11 | 4 | Pomeranz Mark | MOTS | Stock Option (right to buy) | D | 0,74 | 75 000 | 75 000 | |||||
| 2020-11-13 | 2020-11-11 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 0,74 | 190 000 | 190 000 | |||||
| 2020-11-13 | 2020-11-11 | 4 | Taylor Andrew Lawrence | MOTS | Stock Option (right to buy) | D | 0,74 | 85 000 | 85 000 | |||||
| 2020-10-13 | 2020-10-12 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 9 430 | 49 130 | ||||||
| 2020-10-13 | 2020-10-12 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 9 430 | 39 130 | ||||||
| 2020-10-13 | 2020-10-12 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 11 132 | 89 665 | ||||||
| 2020-10-13 | 2020-10-12 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 10 346 | 39 746 | ||||||
| 2020-10-13 | 2020-10-12 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 18 466 | 71 373 | ||||||
| 2020-07-13 | 2020-07-10 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 14 600 | 52 907 | ||||||
| 2020-07-13 | 2020-07-10 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 7 200 | 39 700 | ||||||
| 2020-07-13 | 2020-07-10 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 7 700 | 78 533 | ||||||
| 2020-07-13 | 2020-07-10 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 7 900 | 29 400 | ||||||
| 2020-07-13 | 2020-07-10 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 7 200 | 29 700 | ||||||
| 2020-06-12 | 2020-06-11 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 1,17 | 200 000 | 200 000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | Pomeranz Mark | MOTS | Stock Option (right to buy) | D | 1,17 | 80 000 | 80 000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | Taylor Andrew Lawrence | MOTS | Stock Option (right to buy) | D | 1,17 | 90 000 | 90 000 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Hochman David P | MOTS | Stock Option (right to buy) | D | 2,16 | 20 000 | 20 000 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 20 000 | 38 307 | ||||||
| 2020-02-07 | 2019-12-31 | 4 | Hochman David P By NSH 2008 Family Trust | MOTS | Warrants (right to buy) | I | 5,00 | 2 019 | 2 019 | |||||
| 2020-02-07 | 2019-12-31 | 4 | Hochman David P By NSH 2008 Family Trust | MOTS | Warrants (right to buy) | I | 5,00 | 1 766 | 1 766 | |||||
| 2020-02-07 | 2019-12-31 | 4 | Hochman David P | MOTS | Warrants (right to buy) | D | 5,00 | 299 | 599 | |||||
| 2020-02-07 | 2019-12-31 | 4 | Hochman David P | MOTS | Warrants (right to buy) | D | 5,00 | 305 | 305 | |||||
| 2020-02-07 | 2020-02-06 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Stock Option (right to buy) | D | 2,16 | 12 500 | 12 500 | |||||
| 2020-02-07 | 2020-02-06 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 12 500 | 22 500 | ||||||
| 2020-02-07 | 2020-02-06 | 4 | Pruden Gary J | MOTS | Stock Option (right to buy) | D | 2,16 | 12 500 | 12 500 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 12 500 | 70 833 | ||||||
| 2020-02-07 | 2020-02-06 | 4 | Korangy Shervin J | MOTS | Stock Option (right to buy) | D | 2,16 | 12 500 | 12 500 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 12 500 | 32 500 | ||||||
| 2020-02-07 | 2020-02-06 | 4 | Sherman Darren | MOTS | Stock Option (right to buy) | D | 2,16 | 12 500 | 12 500 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 12 500 | 21 500 | ||||||
| 2020-02-07 | 2020-02-06 | 4 | Pomeranz Mark | MOTS | Stock Option (right to buy) | D | 2,16 | 40 336 | 40 336 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 40 336 | 94 857 | ||||||
| 2020-02-07 | 2020-02-06 | 4 | Taylor Andrew Lawrence | MOTS | Stock Option (right to buy) | D | 2,16 | 46 098 | 46 098 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 46 098 | 72 682 | ||||||
| 2020-02-07 | 2020-02-06 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 2,16 | 103 720 | 103 720 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 103 720 | 321 701 | ||||||
| 2019-11-20 | 2019-11-20 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 1,5400 | 10 000 | 15 | 217 981 | ||||
| 2019-11-19 | 2019-11-18 | 4 | Jacobs Gary E. By Jacobs Investment Company | MOTS | Common Stock, par value $0.0001 per share | I | 1,5400 | 17 000 | 26 | 771 289 | ||||
| 2019-07-01 | 2019-06-27 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 3,0000 | 1 000 000 | 3 000 | 4 210 542 | ||||
| 2019-07-01 | 2019-07-01 | 4 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock | I | 2,9896 | 5 000 | 15 | 30 000 | ||||
| 2019-07-01 | 2019-07-01 | 4 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock | I | 3,0158 | 35 000 | 106 | 135 000 | ||||
| 2019-07-01 | 2019-06-27 | 4 | FEINBERG LARRY N | MOTS | Common Stock | I | 3,0000 | 25 000 | 75 | 25 000 | ||||
| 2019-07-01 | 2019-06-27 | 4 | FEINBERG LARRY N | MOTS | Common Stock | I | 3,0000 | 100 000 | 300 | 100 000 | ||||
| 2019-07-01 | 2019-06-27 | 4 | FEINBERG LARRY N | MOTS | Common Stock | I | 3,0000 | 138 698 | 416 | 550 698 | ||||
| 2019-07-01 | 2019-06-27 | 4 | FEINBERG LARRY N | MOTS | Common Stock | I | 3,0000 | 93 566 | 281 | 379 566 | ||||
| 2019-07-01 | 2019-06-27 | 4 | FEINBERG LARRY N | MOTS | Common Stock, par value $0.0001 per share ("Common Stock") | I | 3,0000 | 634 402 | 1 903 | 2 711 402 | ||||
| 2019-07-01 | 2019-07-01 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 3,0000 | 8 333 | 25 | 58 333 | ||||
| 2019-07-01 | 2019-07-01 | 4 | Hochman David P By DPH 2008 Trust | MOTS | Common Stock, par value $0.0001 per share | I | 3,0000 | 10 000 | 30 | 110 000 | ||||
| 2019-07-01 | 2019-07-01 | 4 | Jacobs Gary E. By Jacobs Investment Company LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3,0000 | 8 333 | 25 | 754 289 | ||||
| 2019-07-01 | 2019-07-01 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 3,0000 | 3 333 | 10 | 207 981 | ||||
| 2019-07-01 | 2019-07-01 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 3,0000 | 1 000 | 3 | 54 521 | ||||
| 2019-05-24 | 2019-05-22 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 3,3800 | 5 000 | 17 | 204 648 | ||||
| 2019-02-15 | 2019-02-13 | 4 | Sherman Darren | MOTS | Stock Option (right to buy) | D | 4,30 | 25 000 | 25 000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Hochman David P | MOTS | Stock Option (right to buy) | D | 4,30 | 40 000 | 40 000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Pruden Gary J | MOTS | Stock Option (right to buy) | D | 4,30 | 25 000 | 25 000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Korangy Shervin J | MOTS | Stock Option (right to buy) | D | 4,30 | 25 000 | 25 000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Stock Option (right to buy) | D | 4,30 | 25 000 | 25 000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Jacobs Gary E. | MOTS | Stock Option (right to buy) | D | 4,30 | 25 000 | 25 000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Pomeranz Mark | MOTS | Stock Option (right to buy) | D | 4,30 | 128 641 | 128 641 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 42 880 | 53 521 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Taylor Andrew Lawrence | MOTS | Stock Option (right to buy) | D | 4,30 | 70 753 | 70 753 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 23 584 | 26 584 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 4,30 | 28 944 | 28 944 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 174 648 | 199 648 | ||||||
| 2019-01-17 | 2018-12-24 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 2,7000 | 400 000 | 1 080 | 3 210 541 | ||||
| 2019-01-17 | 2018-02-14 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 5,0000 | 10 000 | 50 | 2 810 541 | ||||
| 2018-12-26 | 2018-12-24 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 2,7000 | 1 000 | 3 | 3 000 | ||||
| 2018-12-26 | 2018-12-24 | 4 | Hochman David P By DPH 2008 Trust | MOTS | Common Stock, par value $0.0001 per share | I | 2,7000 | 20 000 | 54 | 100 000 | ||||
| 2018-12-26 | 2018-12-24 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 2,7000 | 2 500 | 7 | 10 641 | ||||
| 2018-12-26 | 2018-12-24 | 4 | Jacobs Gary E. By Jacobs Investment Company | MOTS | Common Stock, par value $0.0001 per share | I | 2,7000 | 10 000 | 27 | 745 956 | ||||
| 2018-12-26 | 2018-12-24 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 2,7000 | 10 000 | 27 | 25 000 | ||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 3 187 000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 4 852 000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 3 061 000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 3 187 000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 4 852 000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 3 061 000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 3 187 000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 4 852 000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 3 061 000 | ||||||||
| 2018-11-27 | 2018-11-27 | 4 | Jacobs Gary E. By Jacobs Investment Company | MOTS | Common Stock, par value $0.0001 per share | I | 3,4800 | 7 100 | 25 | 735 956 | ||||
| 2018-11-21 | 2018-11-19 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 3,4800 | 15 000 | 52 | 15 000 | ||||
| 2018-11-21 | 2018-11-16 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 3,4900 | 15 000 | 52 | 18 000 | ||||
| 2018-11-09 | 2018-11-08 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 3,78 | 495 000 | 495 000 | |||||
| 2018-06-11 | 3 | Orchestra BioMed, Inc. | MOTS | Common Stock, par value $0.0001 per share | D | 4 000 000 | ||||||||
| 2018-06-11 | 3 | Orchestra BioMed, Inc. | MOTS | Common Stock, par value $0.0001 per share | D | 4 000 000 | ||||||||
| 2018-06-11 | 3 | Orchestra BioMed, Inc. | MOTS | Common Stock, par value $0.0001 per share | D | 4 000 000 | ||||||||
| 2018-06-04 | 2018-05-31 | 4 | Hochman David P By Orchestra BioMed, Inc. | MOTS | Common Stock, par value $0.0001 per share | I | 2 000 000 | 2 000 000 | ||||||
| 2018-06-04 | 2018-05-31 | 4 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | −1 000 000 | 109 792 | ||||||
| 2018-06-04 | 2018-05-31 | 4 | Sherman Darren By Orchestra BioMed, Inc. | MOTS | Common Stock, par value $0.0001 per share | I | 2 000 000 | 2 000 000 | ||||||
| 2018-06-04 | 2018-05-31 | 4 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | −1 000 000 | 109 792 | ||||||
| 2018-06-04 | 2018-05-31 | 4 | Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | D | −1 000 000 | 591 481 | ||||||
| 2018-06-04 | 2018-05-31 | 4 | ABV, LLC By Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | −1 000 000 | 591 481 | ||||||
| 2018-05-21 | 2018-05-18 | 4 | Jacobs Gary E. By Jacobs Investment Company | MOTS | Common Stock, par value $0.0001 per share | I | 5,2400 | 5 000 | 26 | 728 856 | ||||
| 2018-05-21 | 2018-05-17 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 5,5500 | 1 000 | 6 | 9 000 | ||||
| 2018-05-21 | 2018-05-17 | 4 | Hochman David P By DPH 2008 Trust | MOTS | Common Stock, par value $0.0001 per share | I | 5,4900 | 5 000 | 27 | 80 000 | ||||
| 2018-03-28 | 2018-03-27 | 4 | Pruden Gary J | MOTS | Stock Option (right to buy) | D | 4,58 | 50 000 | 50 000 | |||||
| 2018-02-21 | 3/A | Sherman Darren By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 1 094 930 | ||||||||
| 2018-02-21 | 3/A | Hochman David P By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 1 094 930 | ||||||||
| 2018-02-21 | 3/A | Orchestra Medical Ventures II GP, LLC By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 0 | ||||||||
| 2018-02-21 | 2018-02-16 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Warrant (right to buy) | I | 5,00 | 180 055 | 180 055 | |||||
| 2018-02-21 | 2018-02-16 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Series A Convertible Preferred Stock | I | −256 386 | 0 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 5,0000 | 1 000 000 | 5 000 | 2 800 541 | ||||
| 2018-02-21 | 2018-02-16 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 256 386 | 1 800 541 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Warrants (right to buy) | I | 5,00 | 115 997 | 115 997 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Warrants (right to buy) | I | 5,00 | 106 980 | 106 980 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P | MOTS | Warrants (right to buy) | D | 5,00 | 300 | 300 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Series A Convertible Preferred Stock | I | 0,00 | −65 038 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Series A Convertible Preferred Stock | I | 0,00 | −99 748 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P | MOTS | Series A Convertible Preferred Stock | D | 0,00 | −750 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 65 038 | 1 159 968 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 99 748 | 1 109 792 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 5,0000 | 40 000 | 200 | 1 010 044 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 750 | 78 000 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 75 000 | 375 | 77 250 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 50 000 | 250 | 50 000 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Jacobs Gary E. By Jacobs Investment Company LLC | MOTS | Warrant (right to buy) | I | 5,00 | 72 386 | 72 386 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Jacobs Gary E. By Jacobs Investment Company LLC | MOTS | Series A Convertible Preferred Stock | I | 0,00 | −63 289 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Jacobs Gary E. By Jacobs Investment Company LLC | MOTS | Common Stock, par value $0.0001 per share | I | 63 289 | 723 856 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Jacobs Gary E. | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 5 000 | 25 | 9 100 | ||||
| 2018-02-21 | 2018-02-16 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 10 000 | 50 | 10 000 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Warrants (right to buy) | I | 5,00 | 115 997 | 115 997 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Warrants (right to buy) | I | 5,00 | 106 980 | 106 980 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren | MOTS | Warrants (right to buy) | D | 5,00 | 300 | 300 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Series A Convertible Preferred Stock | I | 0,00 | −65 038 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Series A Convertible Preferred Stock | I | 0,00 | −99 748 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren | MOTS | Series A Convertible Preferred Stock | D | 0,00 | −750 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 65 038 | 1 159 968 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 99 748 | 1 109 792 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 5,0000 | 40 000 | 200 | 1 010 044 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 750 | 8 000 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 5 000 | 25 | 7 250 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 8 000 | 40 | 8 141 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Ascent Biomedical Ventures II, L.P. | MOTS | Warrant (right to buy) | D | 5,00 | 159 149 | 159 149 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Ascent Biomedical Ventures II, L.P. | MOTS | Series A Convertible Preferred Stock | D | 0,00 | −144 352 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | D | 144 352 | 1 591 481 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 2 000 | 10 | 2 000 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 20 000 | 100 | 20 000 | ||||
| 2018-02-21 | 2018-02-16 | 4 | ABV, LLC By Ascent Biomedical Ventures Synecor, L.P. | MOTS | Warrant (right to buy) | I | 5,00 | 61 125 | 61 125 | |||||
| 2018-02-21 | 2018-02-16 | 4 | ABV, LLC By Ascent Biomedical Ventures II, L.P. | MOTS | Warrant (right to buy) | I | 5,00 | 159 149 | 159 149 | |||||
| 2018-02-21 | 2018-02-16 | 4 | ABV, LLC By Ascent Biomedical Ventures Synecor, L.P. | MOTS | Series A Convertible Preferred Stock | I | 0,00 | −26 241 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | ABV, LLC By Ascent Biomedical Ventures II, L.P. | MOTS | Series A Convertible Preferred Stock | I | 0,00 | −144 352 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | ABV, LLC By Ascent Biomedical Ventures Synecor, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 26 241 | 611 241 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | ABV, LLC By Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 144 352 | 1 591 481 | ||||||
| 2018-02-13 | 3 | Sherman Darren By Accelerated Technologies, Inc. | MOTS | Common Stock, par value $0.0001 per share | I | 2 253 572 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Orchestra Medical Ventures II Reserve, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2 285 426 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3 172 118 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3 297 004 | ||||||||
| 2018-02-13 | 3 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 2 204 324 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3 172 118 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3 297 004 | ||||||||
| 2018-02-13 | 3 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 2 204 324 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Accelerated Technologies, Inc. | MOTS | Common Stock, par value $0.0001 per share | I | 2 253 572 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Orchestra Medical Ventures II Reserve, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2 285 426 | ||||||||
| 2018-02-13 | 3 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 282 | ||||||||
| 2018-02-13 | 3 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 282 | ||||||||
| 2018-02-13 | 3 | Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | D | 2 894 258 | ||||||||
| 2018-02-13 | 3 | Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | D | 2 894 258 | ||||||||
| 2018-02-13 | 3 | Orchestra Medical Ventures II GP, LLC By Orchestra Medical Ventures II Reserve, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2 231 678 | ||||||||
| 2018-02-13 | 3 | Orchestra Medical Ventures II GP, LLC By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3 118 370 | ||||||||
| 2018-02-13 | 3 | Orchestra Medical Ventures II GP, LLC By Orchestra Medical Ventures II Reserve, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2 231 678 | ||||||||
| 2018-02-13 | 3 | Orchestra Medical Ventures II GP, LLC By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3 243 256 | ||||||||
| 2018-02-13 | 3 | Orchestra Medical Ventures II GP, LLC By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3 118 370 | ||||||||
| 2018-02-13 | 3 | Orchestra Medical Ventures II GP, LLC By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3 243 256 | ||||||||
| 2018-02-13 | 3 | Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | D | 2 189 860 | ||||||||
| 2018-02-13 | 3 | Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | D | 2 189 860 | ||||||||
| 2018-02-13 | 3 | Jacobs Gary E. By Jacobs Investment Company LLC | MOTS | Common Stock, par value $0.0001 per share | I | 1 325 234 | ||||||||
| 2018-02-13 | 3 | Jacobs Gary E. | MOTS | Common Stock, par value $0.0001 per share | D | 668 767 | ||||||||
| 2018-02-13 | 3 | Jacobs Gary E. By Jacobs Investment Company LLC | MOTS | Common Stock, par value $0.0001 per share | I | 1 325 234 | ||||||||
| 2018-02-13 | 3 | Jacobs Gary E. | MOTS | Common Stock, par value $0.0001 per share | D | 668 767 | ||||||||
| 2018-02-13 | 3 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 3 088 310 | ||||||||
| 2018-02-13 | 3 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 3 088 310 | ||||||||
| 2018-02-13 | 3 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 3 088 310 | ||||||||
| 2018-02-13 | 3 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 3 088 310 | ||||||||
| 2018-02-13 | 3 | ABV, LLC By Ascent Biomedical Ventures Synecor, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2 617 129 | ||||||||
| 2018-02-13 | 3 | ABV, LLC By Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3 479 258 | ||||||||
| 2018-02-13 | 3 | ABV, LLC By Ascent Biomedical Ventures Synecor, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2 617 129 | ||||||||
| 2018-02-13 | 3 | ABV, LLC By Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3 479 258 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3 297 004 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Orchestra Medical Ventures II Reserve, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2 285 426 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Accelerated Technologies, Inc. | MOTS | Common Stock, par value $0.0001 per share | I | 2 253 572 | ||||||||
| 2018-02-13 | 3 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 2 204 324 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3 172 118 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Orchestra Medical Ventures II Reserve, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2 285 426 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3 297 004 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Accelerated Technologies, Inc. | MOTS | Common Stock, par value $0.0001 per share | I | 2 253 572 | ||||||||
| 2018-02-13 | 3 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 2 204 324 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3 172 118 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
